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Antimicrobial and antitumor activities of resveratrol, a compound found mainly in grapes, have 
already been demonstrated. However, its low bioavailability is a limiting factor for therapeutic 
application. Polymeric micelles can be an approach to solve this problem since they can encapsulate 
hydrophobic substances. We developed and characterized micellar formulations containing 
resveratrol and evaluated their cytotoxic and antimicrobial effects. The formulations were prepared 
by the cold dispersion method with different concentrations of F127 (5 or 10% w/w) and resveratrol 
(500 or 5000 µM). The formulations were characterized according to size, polydispersity index, 
pH, encapsulation rate and in vitro release. Cytotoxic effect was evaluated on a bladder cancer 
cell line and antimicrobial effect was evaluated on E. coli, S. aureus and C. albicans. One of the 
formulations (10% w/w of F127 and 5000 µM of resveratrol) was a monodispersed solution with 
high encapsulation rate, thus it was chosen for the cytotoxicity and antimicrobial assays. MS-
10+RES-3 was able to preserve the antimicrobial and cytotoxic activity of resveratrol. This is the 
first study that evaluated antimicrobial potential and cytotoxicity of micelles containing resveratrol 
on bladder cancer cells and the results showed that micellar nanostructures could ensure the 
maintenance of the biological activity of resveratrol.
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INTRODUCTION
Resveratrol (trans-3, 4’, 5-trihydroxystilbene) is 
a polyphenolic compound found naturally in grapes, 
blueberries, raspberries and peanuts (Wang, Liu, 
Chen, 2013). Resveratrol has been reported to present 
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antimicrobial (Lee et al., 2014; Lee et al., 2015) and 
antitumoral activities (Selvaraj et al., 2016; Nie et al., 
2015). In addition to some in vitro studies, antimicrobial 
and antitumoral activities have also been demonstrated in 
vivo (Wu et al., 2014; Kumar, Rimando, Levenson, 2017; 
Euba et al., 2017) and in clinical studies (Patel et al., 2010).
For over a decade, it has been shown that resveratrol 
has low solubility and low bioavailability due to poor 
absorption and rapid metabolization (Amri et al., 2012), 
both physicochemical and pharmacokinetic properties 
that make resveratrol difficult to use clinically. Several 
nanoformulations with resveratrol have been developed 
for the treatment of tumors and infections (Santos, Veiga, 
Ribeiro, 2011; Figueiró et al., 2013; Friedrich et al., 2015; 
Vitonyte et al., 2017). Furthermore, resveratrol has some 
stability issues, being extremely photosensitive (Francioso 
et al., 2014) and unstable at alkaline pH and higher 
temperatures (Zupancic, Lavric, Kristl, 2015). However, 
these problems could be improved using nanoformulations 
and should be considered during their development. 
Polymeric micelles have been studied as a drug 
carrier system, in particular for enhancing the solubility 
of hydrophobic drugs, a characteristic of many antitumor 
and antimicrobial agents. Some authors have shown that 
polymeric micelles are a suitable in vivo nanocarrier 
to deliver drugs with low solubility by intravenous 
or subcutaneous routes (Gu et al., 2017; Pellosi et al., 
2016; Yu et al., 2015). Furthermore, incorporation of 
substances in the hydrophobic core of micelles may 
prevent clearance by the mononuclear phagocyte system 
in the spleen and liver, since the hydrophilic corona 
from polymeric micelles plays an important role in 
preventing opsonization (Rey-Rico, Cucchiarini, 2018). 
An in vivo pharmacokinetic study demonstrated that 
the area under the curve (AUC) value of resveratrol 
micelles was 2.73-fold higher in comparison with free 
resveratrol. Moreover, the mean residence time (MRT) 
of resveratrol micelles was significantly longer than 
that of resveratrol solution. The authors deduced that 
micelles could improve the availability of resveratrol by 
the slow release of drug from the micelles and evasion of 
clearance (Hao et al., 2017).
Micelles can be obtained by different methods, 
such as solvent casting, dialysis, oil/water emulsion, 
cold dispersion and others. The micelle preparation 
method is an essential factor in determining the overall 
micelle properties, including size, polydispersity and 
loading efficiency as well as its suitability for industrial 
scale production (Hussein, Youssry, 2018).
Pluronics® are triblock copolymers of propylene 
oxide (PO) and ethylene oxide (EO) that can 
spontaneously self-assemble to form micelles (Kabanov, 
Alakhov, 2002). These copolymers are included on 
the US Federal Drug Administration list as safe and 
biocompatible compounds (Oerlemans et al., 2010). 
Furthermore, they are known to solubilize hydrophobic 
compounds in the micellar state and have been proven 
to be effective solubilizers of polyphenols, such as 
resveratrol (Wang et al., 2017). Among various types 
of Pluronics®, F127 (F127) has gained considerable 
attention due to its wide range of biomedical applications 
(Akash, Rehman, 2015). 
Therefore, micellar solutions of Pluronic® F127 
containing resveratrol have been developed and 
characterized as a formulation for the treatment of 
microbial (bacterial and fungal) infection and cancer. 
The micellar formulation demonstrated bacteriostatic 
effects against S. aureus, E. coli and C. albicans, and 
furthermore demonstrated cytotoxicity on T24 bladder 
cancer cells. As a result, this formulation may be a good 
strategy for the use of resveratrol in biological systems.
MATERIAL AND METHODS
Material
Pluronic® F127, resveratrol, Dulbecco’s modified 
Eagle’s medium (DMEM), pyrene, triphenyl tetrazolium 
chloride, tetracycline, ketoconazole, penicillin G and 
streptomycin were purchased from Sigma-Aldrich® (St 
Louis, USA). Müeller-Hinton and Sabouraud medium 
were purchased from Himedia (Mumbai, India). 
Amphotericin B was purchased from Cristália (Itapira, 
Brazil). Methanol (HPLC grade) was purchased from 
Merck® (Darmstadt, Germany). Fetal bovine serum was 
purchased from Cultilab Ltd. (Campinas, Brazil). Cell 
Proliferation Kit II (XTT) was purchased from Roche 
Diagnostics® (Mannheim, Germany). Culture medium 
DMEM without phenol red was purchased from 
Invitrogen® (Carlsbad, USA).
Preparation of micellar solutions 
by cold dispersion method 
A weighed amount of Pluronic® F127 (5 or 10% wt/
wt) was added to a becker containing ultrapure water 
and kept under moderate magnetic stirring in an ice 
bath (4-6 ºC) until complete dispersion of the polymer. 
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The solution was kept at 10 ºC for 24 hours to allow 
the complete dissolution of the polymer. Subsequently, 
the resveratrol was added and dispersed under vigorous 
stirring at room temperature. After preparation, 
all formulations were filtered on a 0.45 µm filter to 
eliminate the non-encapsulated resveratrol (Rijcken 
et al., 2007). The theoretical resveratrol concentration 
added to the micellar solutions were 500 and 5000 µM. 
Micelles without resveratrol were also prepared and 
used as controls.
Determination of mean size and 
zeta potential of the micelles
The particle size and zeta potential values of 
micelles were determined with a Zetasizer (Malvern, 
model Zetasizer Nano series - Nano ZS) at 25°C. The 
mean particle size was measured based on photo-
correlation spectroscopy technique and the zeta potential 
was determined based on electrophoretic mobility 
measurements (Liu et al., 2017; Wang et al., 2017). The 
experiments were conducted in triplicate.
Determination of pH
The pH measurement of the formulations was 
determined by the use of a pHmeter (Instrutemp model 
mPA201). The values were determined in triplicate.
Quantification of resveratrol
Resveratrol was quantified by HPLC/UV method 
as previously described (Trela, Waterhouse, 1996). The 
equipment used was the Waters e2695 coupled to a UV/Vis 
Waters 2485 detector. The UV/Vis detector was set at 306 
nm. Separation was done on a C18 column (Phenomenex, 
Luna 5µ, 100Å, 150 x 4.6 mm) at 25 ºC, using methanol 
and ultrapure water (50:50) as mobile phase at a flow rate 
of 0.8 mL/min. The injection volume was 5.0 uL and the 
run time for resveratrol was approximately 8 minutes. This 
method was used to calculated encapsulation efficiency 
and resveratrol in vitro release.
Encapsulation efficiency
The amount of resveratrol present on micelles was 
determined with HPLC/UV method previous described 
(Trela, Waterhouse, 1996). The formulation was 
filtrated on 0.45 µm filter to remove non-encapsulated 
resveratrol and diluted on methanol/water (50:50). 
The encapsulation efficiency was calculated by the 
following equation: 
Micellar microenvironment analysis
Pyrene is a fluorescent probe often used to evaluate 
changes in the microenvironment of a micellar system 
(Perry et al., 2011). Measurements of the pyrene emission 
spectra were conducted in methanol, water and then in 
methanol with different concentrations of resveratrol. 
Subsequently, micelles with and without resveratrol 
were labeled with pyrene and the emission spectra were 
measured. The emission spectra were measured between 
the wavelengths 350-500 nm with excitation at 335 nm.
Resveratrol in vitro release assay
The in vitro release assay of resveratrol encapsulated 
at micelles was performed by dialysis membrane 
diffusion method at 37°C for 48 h, maintaining constant 
agitation in a horizontally stirred incubator (Dubnoff 
304D). The donor medium was composed of 1 mL of 
formulation containing about 0.5 µM resveratrol, and the 
receptor medium was composed of phosphate buffered 
saline with 1% tween 80 at sink conditions (Fonseca, 
2016). At pre-determined times, 1 mL of the receptor 
medium was collected and the same volume was 
replaced with fresh medium. The fraction collected was 
quantified directly, without dilution, with the HPLC/UV 
method previous described.
Cytotoxicity on tumor cells
The human urothelial carcinoma cell line T24 
(from a high grade tumor) was purchased from the 
Cell Bank of the Federal University of Rio de Janeiro 
(Rio de Janeiro, Brazil). Cells were maintained in 
culture medium Dulbecco’s Modified Eagle (DMEM) 
supplemented with 10% bovine fetal serum, 100 U/ml 
penicillin G, 100 U/ml streptomycin and 2,5 µg/mL 
amphotericin B in an atmosphere of 5% CO
2
 at 37 ºC. 
Cytotoxicity was assessed using the Cell 
Proliferation Kit II (XTT, Roche®). Briefly, 1×104 T24 
cells were seeded into 96-well culture plates. After 24 
hours, the cells were treated with different concentrations 
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of the micellar solutions containing resveratrol (50, 100, 
150, 200 and 250 µM) or with free resveratrol during 24 
hours. The concentrations and the time of treatment were 
defined based on the study conducted by Bai et al. (2009). 
Cells treated with micellar solutions without resveratrol 
were used as controls. 24 hours after incubation, the 









, 0.35 g NaHCO
3
, 1 g 
glucose and 8 g NaCl in 1 L·H
2
O). After washing, 12 uL 
of XTT test solution (1 mL XTT labeling solution/20 uL 
of electron-coupling reagent) were added to each well, 
and the absorbance was measured at 492 and 690 nm 
after 90 minutes. Absorbance results are proportional to 
the percentage of viable cells. Tests were conducted in 
triplicate. The results of absorbance were analyzed by 
One-way analysis of variance (ANOVA) with post hoc 
Tukey test using the software GraphPad Prism 6.0. A 
value of p < 0.05 was considered statistically significant.
Antimicrobial activity
In vitro assays were performed using three 
microorganisms, representing respectively each main 
microbial class (gram positive and gram negative 
bacteria and pathogenic yeast): Staphylococcus aureus 
(ATCC 25923); Escherichia coli (ATCC 25922) and 
Candida albicans (ATCC 14408). Bacteria were 
cultivated in Müeller-Hinton medium by 24 h at 37 °C 
and yeast was cultivated in Sabouraud medium by 48 h 
at 37 °C. All inoculums were prepared by using direct 
colony suspension method in saline (0.9% NaCl) with 
colonies selected from a 24 h or 48 h agar plate, before 
each assay. The suspension was adjusted to achieve a 
turbidity equivalent to the 0.5 McFarland standard (1 x 
108 CFU/mL). Antimicrobial effect of resveratrol and 
its formulations were evaluated by the microdilution 
method (CLSI, 2012). In 96-well plates, serial dilutions 
of 1:2 were made to obtain the same concentration 
(from 250 to 0.12 µM) of resveratrol for both free and 
formulations. The inoculums (1 x 108 CFU/mL) were 
diluted 1:100 in Müeller-Hinton broth and were added 
in each well to obtain a final assay with 5 x 105 CFU/
mL (CLSI, 2012). For negative control only Müeller-
Hinton broth and inoculum were added. Tetracycline 
(100.0 µg/mL) or Ketoconazole (100.0 µg/mL) were used 
as positive control for bacteria or yeast, respectively. 
Formulation without resveratrol was used as formulation 
control and the control of the broth was made without 
inoculum. The plates were incubated for 24 h or 48 h, 
for bacteria or yeast, respectively at 37°C. After the 
incubation, triphenyl tetrazolium chloride TTC (0.25 
mg/mL) were added and the plates were again incubated 
for three hours. Since resveratrol is an antioxidant agent 
and the TTC is a redox indicator, we used a control with 
resveratrol and TTC (without microorganism) to ensure 
no interference from the compound influenced the 
results. The absorbance at 650 nm was determined in 
an ELISA plate reader (Molecular Devices®). The results 
of absorbance were analyzed by One-way analysis of 
variance (ANOVA) with post hoc Tukey test using the 
software GraphPad Prism 6.0. A value of p < 0.05 was 
considered statistically significant.
RESULTS AND DISCUSSION
Many studies have demonstrated in vitro 
antimicrobial and cytotoxic properties of resveratrol (Nie 
et al., 2015; Selvaraj et al., 2016; Ji et al., 2015; Taylor 
et al., 2014; Hwang, Lim, 2015). However, there are no 
reports in the literature on the activity of resveratrol 
micellar systems against bacteria and yeast. Similarly, 
there are very few studies about polymeric micelles 
containing resveratrol for cancer treatment (Hao et al., 
2017), and none about this type of formulation’s effect 
on bladder cancer cells.
Several approaches have been investigated for 
Pluronic® F127 micelle preparation. Direct dissolution 
is a method that involves dissolving both the polymer 
and the drug in an aqueous solvent. Another strategy, 
implying the use of organic solvents, is relevant when 
both the copolymer and the drug are not readily soluble 
in water. The copolymer and the drug are dissolved in 
a common solvent which is then removed, usually by 
evaporation (Bodratti, Alexandridis, 2018). In this study, 
the micelles were prepared by using cold dispersion, 
because it is preferred when the polymeric materials 
are only moderately hydrophobic in nature (Bodratti, 
Alexandridis, 2018), as is the case with Pluronics® 
Furthermore there is no risk of residual organic solvent. 
This is an advantage of our formulation compared to 
that previously described by Hao et al. (2017), since 
those authors used a method with organic solvent.
Polymeric micelles have a critical micelle 
concentration (CMC) that is the lowest concentration 
limit for polymers to produce a micelle (Owen, Chan, 
Shoichet, 2012). When diluted below CMC, polymer 
micelles are gradually disintegrated into unimers and this 
can affect the solubilizing efficacy of the formulation. 
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For this reason, we chose to use quantities of F127 (5 and 
10% w/w) that even after dilutions have concentrations 
higher than its CMC (2.8 µM) (Stammet et al., 2010). 
The composition of each formulation is shown in Table 
I. Additionally, F127 has the characteristic of forming 
hydrogels at high concentrations (> 20% w/w) (Giuliano 
et al., 2018), which was avoided. 
The ability of the polymeric micelles to increase the 
aqueous solubility of drugs is due to their hydrophobic 
core that provides a suitable microenvironment to 
accommodate hydrophobic substances (Alvarez-Lorenzo, 
Sosnik, Concheiro, 2011). In this way, the solubility of 
resveratrol in F127 micellar solutions (5000 µM) was about 
30 times higher than its solubility in pure water, which is 
about 131 µM (Liu, Jiang, Han, 2012), probably due to the 
incorporation of the drug into the core of the micelles. 
The mean diameter, zeta potential and pH value of 
each formulation are summarized in Table I and the size 
distribution is shown in Figure 1. The size of micelles is a 
very important parameter for drug delivery efficacy. The 
size variation, inside the nanoscale range, affects the blood 
circulation time and the bioavailability of the encapsulated 
drug (Kabanov et al., 2002). Considering several variants, 
such as renal clearance, penetration of small capillaries, 
capture by the phagocyte system and circulation time, the 
preferred size range for drug delivery using nanoscale 
particles is from 10 to 100 nm (Kabanov, Alakhov, 2002), 
as with those observed for the formulations MS-5+RES-2 
and MS-10+RES-3. Furthermore, all formulations 
containing resveratrol could be classified as monodisperse 
(PI < 0.3), while the formulations without resveratrol were 
polidisperse (PI > 0.3) (Gaumet et al., 2008).
The micelles containing resveratrol exhibited 
a larger size than the micelles without resveratrol, 
indicative that the F127 micelles encapsulated the 
compound. Interestingly, the size increase was not 
directly proportional to the amount of resveratrol added, 
that is, MS-10+RES-1 containing 500 µM of resveratrol is 
larger than MS-5+RES-2 and MS-10+RES-3 containing 
5000 µM of resveratrol. We suggest that this effect 
occurred due to the aggregation of two or more micelles, 
since the formulation MS-10+RES-1 showed the lowest 
value, per module, of zeta potential (Varshosaz et al., 
2018; Varshosaz et al., 2014) and greater zeta potential 
values (> 30 mV, per module) are required to stabilize 
nanoparticles effectively by electric repulsion in liquid 
medium (Clogston, Patri, 2011).
Although the long-term stability of the micelles 
has not been evaluated, we suggest that they can be 
lyophilized to maintain their characteristics. Pepić et al. 
(2014) showed that the lyophilizing process of Pluronic® 
F127/L121 mixed micelles resulted in a reconstituted 
product with mostly similar hydrodynamic diameter 
and polydispersity index values to the fresh micelle 
formulation (Pepić et al., 2014).
Table II shows the results of resveratrol quantified in 
the formulations. The formulations showed between 95.9 
and 96.8% encapsulation efficiency. Li et al. also showed 
high encapsulation rates when preparing mixed micelles 
(F127 and another Pluronic®) containing resveratrol 
using the thin-film hydration method (Li et al., 2015). 
It was not possible to determinate the encapsulation 
efficiency of MS-5+RES-2 due to instability of the 
formulation one week after preparation. 












MS-10+RES-1 500 10 209.70 ± 81.71 0.26 ± 0.03 -15.71 ± 0.51 6.59 + 0.03
MS-5+RES-2 5000 5 25.67± 3.96 0.30 ± 0.03 -22.80 ± 6.68 6.68 + 0.03
MS-10+RES-3 5000 10 28.32 ± 3.24 0.33 ± 0.15 -29.20 ± 0.32 6.62 + 0.05
MS-5 - 5 6.30 ± 3.19 0.69 ± 0.38 -12.30 ± 6.17 6.76 + 0.03
MS-10 - 10 5.30 ± 0.07 0.42 ± 0.03 -11.20 ± 5.14 6.76 + 0.02
Tamires Cunha Almeida, Janaina Brandão Seibert, Sávio Henrique de Souza Almeida, Tatiane Roquete Amparo, Luiz Fernando de 
Medeiros Teixeira, Jose Mario Barichello, Bruna Bueno Postacchini, Orlando David Henrique dos Santos, Glenda Nicioli da Silva
Page 6/13 Braz. J. Pharm. Sci. 2020;56: e18401
FIGURE 1 - Size distribution of micelles containing resveratrol. (A) MS-10+RES-1; (B) MS-5+RES-2; (C) MS-10+RES-3.
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MS-10+RES-1 500 1.41 484.10 1.36 96.82
MS-5+RES-2 5000 11.41 - - -
MS-10+RES-3 5000 11.41 4795.00 10.94 95.90
RES: resveratrol; F127: Pluronic® F127; MS-10+RES-1: 10% F127 and 500 µM RES; MS-5+RES-2: 5% F127 and 5000 µM 
RES; MS-10+RES-3: 10% F127 and 5000 µM RES.
suggest that the degradation was not the cause of the low 
concentration of resveratrol detected, since no different 
peaks were detected in the chromatogram. The release of 
hydrophobic drugs from structured nanoparticles in the 
form of core-corona is very dependent on the hydrophobic 
properties of the nucleus (Liu, Xiao, Allen, 2004). In the 
case of micelles formed by copolymers, the release rate 
is strongly influenced by the interaction forces occurring 
between the drug and the nucleus of the micelles (Allen et 
al., 2000). Therefore, the high encapsulation rates, which 
were achieved possibly by the strong interaction between 
resveratrol and the nucleus of F127 micelles, corroborates 
the low in vitro release for MS-10+RES-3 formulation. 
The cytotoxic effects of MS-10+RES-3 on bladder 
cancer cells was evaluated. As presented in Figure 4, 
cytotoxicity was observed in the T24 cell line after treatment 
with MS-10+RES-3 and free resveratrol (150, 200 and 
250 µM). Furthermore, the IC
50
 for MS-10+RES-3 (151.5 
µM) was lower than the IC
50
 for free resveratrol (178.73 
µM). Thus, we can affirm that the micellar formulation 
was able to preserve and improve the cytotoxic activity of 
resveratrol. Studies have showed that polymeric micelles 
based on Pluronics® can undergo internalization in cells 
and the general mechanism for absorption is endocytosis 
(Dehghankelishadi et al., 2017). On the other hand, some 
experiments indicate that encapsulated compounds may 
be released from the micelle and enter cells separately 
(Chen et al., 2008). Based on these findings and the in vitro 
release results, which showed low release of resveratrol 
during the same     period used for the treatment of tumor 
cells, we suggest that the significant reduction of viability 
in the T24 cells was due to the internalization of the 
micelles by these cells.
MS-10+RES-3 was chosen for evaluation of its 
antimicrobial and antitumoral activities, based on mean 
particle size, polydispersion index, zeta potential and 
encapsulation efficiency. Further characterization of the 
MS-10+RES-3 formulation was performed.
The results of micellar microenvironment analysis 
using fluorescence are shown in Figure 2. Changes in 
the microenvironment of micellar systems could affect 
the pyrene emission bands (Perry et al., 2011). The 
absorption bands of the MS-10 labeled with pyrene are 
very similar to the pyrene bands in methanol, showing 
the environment in which the pyrene is in micelles is 
more similar to methanol than to water. In this way, it 
can be confirmed that the probe has the ability to enter 
into the micelle. When the formulation MS-10+RES-3 
was analyzed (Figure 2-B), a quenching effect was 
observed, that is, resveratrol promotes the decrease 
of pyrene fluorescence. Figure 2-B shows the gradual 
suppression of pyrene fluorescence in the presence 
of different concentrations of resveratrol. These data 
confirm that the F127 micelles encapsulated resveratrol. 
While the F127 micellization process is strongly 
influenced by temperature (Dumortier et al., 2006), the 
in vitro release assay was conducted at 37 ºC, the same 
temperature at which the biological activities were 
carried out. As presented in Figure 3, there was a very 
low release of resveratrol from the formulation MS-
10+RES-3. In 24 hours, only 0.45% of the resveratrol 
encapsulated in the micelles was released and in 48 hours, 
only 0.91%. Although the in vitro release method used 
has already been described (Fonseca, 2016), it is possible 
that degradation of resveratrol occurs during the process 
due to pH (Zupancic, Lavric, Kristl, 2015). However, we 
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The results of antimicrobial activity are shown 
in Figure 5. For S. aureus, MS-10+RES-3 and free 
resveratrol were able to reduce the number of viable 
microorganisms at all tested concentrations, however, 
the activity of MS-10+RES-3 was higher than free 
resveratrol (p < 0.05 for all tested concentrations). For 
E. coli, MS-10+RES-3 and free resveratrol reduced 
the number of viable microorganisms at 62.5 µM 
and 7.81 µM, respectively. For C. albicans, only the 
highest concentration of free resveratrol and MS-
10+RES-3 (250 µM) reduced the number of viable 
microorganisms. 
FIGURE 2 - Micellar microenvironment analysis using pyrene as a fluorescent probe. (A) Pyrene emission spectra in water, 
methanol and inside the micelles. (B) Pyrene emission spectra in presence of resveratrol and inside the formulation MS-
10+RES-3.
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FIGURE 3 - Release of resveratrol from MS-10+RES-3 formulation. Each point represents the mean values ± standard deviation 
obtained from three experiments.
FIGURE 4 - Percentage of viable T24 cells (logarithmic scale) after treatment with free RES and formulation MS-10+RES-3 
(10% F127 and 5000 µM). * p < 0.05 in relation to control without treatment with resveratrol. Each point represents the mean 
values ± standard deviation obtained from three experiments.
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FIGURE 5 - Percentage of viable S. aureus (A), E. coli (B) and 
C. albicans (C) (logarithmic scale) after treatment with free 
resveratrol and formulation MS-10+RES-3 (10% F127 and 
5000 µM). * p < 0.05 in relation to control without treatment 
with resveratrol. + p < 0.05 in relation to free resveratrol. 
Each point represents the mean values ± standard deviation 
obtained from three experiments.
Lower concentrations of free and formulated 
resveratrol inhibited viability of S. aureus (0.12 µM) 
compared to E. coli (7.81 µM and 62.5 µM, respectively) 
and C. albicans (250 µM). Most of the cell wall of gram 
positive bacteria consists only of a peptidoglycan layer 
and it can be easily penetrated (Rajagopal, Walker, 
2017). The cell wall structure of gram negative bacteria 
is characterized by an outer membrane constituted 
essentially of lipopolysaccharides, which confers 
increased resistance (Rojas et al., 2018). The main 
component of the cell wall of the yeast is chitin and 
ergosterol that modulate the fluidity of the membrane 
and prevent its alterations (Thevissen et al., 2003). Thus, 
generally, drugs have better effect against the gram 
positive bacteria. 
The formulation MS-10+RES-3 showed a significant 
improvement in the antimicrobial activity of resveratrol 
against S. aureus, but not the other microorganisms 
tested, in which it was only able to retain the same 
activity. This finding could be due to differences in their 
cell membrane constituents and structure that provide 
different types of interaction of resveratrol compared 
to the formulation (Glisoni, Sosnik, 2014). Despite the 
fact that the MS-10+RES-3 formulation does not show a 
statistical increase of antimicrobial activity for all tested 
microorganisms, it is still an alternative for resveratrol 
use. Nanostructured systems provide antimicrobial 
advantages such as overcoming physical barriers and 
reaching difficult sites of action (Purro et al., 2018). In 
relation to its use in tumor cell treatment, besides the 
increase in cytotoxic activity, with reduction of the IC
50
, 
this kind of formulation is able to facilitate the delivery 
of drugs to cancer cells through the effect of increased 
permeability and retention (Biswas et al., 2016). 
Furthermore, some micellar formulations have already 
been moved to clinical trials (Lee et al., 2008; Valle et 
al., 2010), showing that they are potential formulations 
for clinical practice. 
To our knowledge, this is the first study that 
evaluated the antimicrobial potential and cytotoxicity 
on bladder cancer cells of micellar formulations 
containing resveratrol, suggesting that converting this 
activity to nano-scale particles can feasibly improve 
its use, since we showed enhancement of the solubility 
of resveratrol and adequate parameters of size, PI and 
zeta potential. Furthermore, this study demonstrated 
the preservation of biological activities from resveratrol 
after its encapsulation in micellar systems. As suggested 
by other authors (Gu et al., 2017; Pellosi et al., 2016; Yu 
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et al., 2015), our micellar formulation could be applied 
by intravenous or subcutaneous routes.
CONCLUSION
We used a simple and rapid method, without the 
use of organic solvents, for improving the solubility 
of resveratrol while maintaining its bacteriostatic and 
cytotoxic activities. These results showed that micellar 
nanostructures could ensure the maintenance of the 
biological activity of resveratrol, besides favoring its 
applicability in biological systems and clinical practices. 
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